IGF-1 and Bone Loss in Women With Anorexia Nervosa.
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 03 Aug 2018
At a glance
- Drugs Mecasermin (Primary) ; Risedronic acid
- Indications Osteoporosis
- Focus Therapeutic Use
- 30 Jul 2018 Status changed from recruiting to active, no longer recruiting.
- 30 Jul 2018 Planned End Date changed from 1 Oct 2018 to 1 Mar 2019.
- 30 Jul 2018 Planned primary completion date changed from 1 Oct 2018 to 1 Mar 2019.